Status:
RECRUITING
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
Lead Sponsor:
Loyola Marymount University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The goal of this pilot clinical trial is to test a disease-tailored, mindfulness-based intervention (Mindful Self-Compassion for Lung Cancer; MSC-LC) in adults diagnosed with lung cancer who are exper...
Detailed Description
Lung cancer stigma (i.e., perceived and internalized negative appraisal and devaluation associated with lung cancer) is a pervasive problem experienced by the majority of lung cancer patients. Notably...
Eligibility Criteria
Inclusion
- Is at least 18 years of age as per self report;
- Has a confirmed lung cancer diagnosis, as per self-report and confirmed by clinician judgment or medical record note;
- Endorses elevated levels of lung cancer stigma (scores \>37.5 on the Lung Cancer Stigma Inventory)
- Able to read and respond to questions in English
Exclusion
- Inability to understand study procedures or informed consent process, or significant personality dysfunction likely to interfere with study participation, as per study clinician's judgment
- Completed a course of Mindful Self-Compassion or an equivalent meditation training in the last year
- Use of antidepressant, anxiolytic, antipsychotic, or mood stabilizing medication(s) for which the dose has been initiated or changed within the 8 weeks prior to study entry
Key Trial Info
Start Date :
May 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 12 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06191939
Start Date
May 6 2024
End Date
January 12 2026
Last Update
July 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Loyola Marymount University
Los Angeles, California, United States, 90045